MediaPharma S.r.l.
A Company focused on the discovery, development and commercialization of monoclonal antibodies for the diagnosis and treatment of cancer and other diseases with unmet medical need.

Managing Team

Stefano Iacobelli, MD – Founder and President

Dr. Stefano Iacobelli is Professor of Medical Oncology at the University “G. D’Annunzio” of Chieti-Pescara, Italy since 1986 and Coordinator of the PhD program in Molecular Oncology since 1991. Dr. Iacobelli has more than 30 years of experience in the translational and clinical Oncology.

He started his career in academic medicine, trained in Europe and the Canada, received board certifications for medical oncology, and served as Chairman of the Italian Consortium of Bio-Oncology since 1993.

Pier Giorgio Natali, MD, PhD – Chief Scientific Officer

Dr. Pier Giorgio Natali received his MD degree from “La Sapienza” University in Rome, Italy and completed his education with diploma from the Board of American Medical Laboratory Immnunology and advanced training in immunopathology at the Scripps Clinic. He was the Director of the Regina Elena Cancer Institute, Division of Immunology in Rome.

He also served as the Director of the Poloncologico Institute, a leading nationwide institute for oncology treatment in Italy. Dr. Natali is one of the most well-known clinical immunologists also doing basic research. Dr. Natali has published over 350 studies with high Citation Index. He belongs to the Advisory Board of the “CR Journal” edited by the American Association for Cancer Research

Riccardo Palumbo, PhD – VP Business Management

Riccardo Palumbo received his degree in Economics at the University “Federico II” of Naples, Italy. He is Member of Board of Directors and Professor of Accounting at the University “G. D’Annunzio” of Chieti-Pescara, Italy. He has been Visiting Professor at the University of Sydney, and Visiting Scholar at the Capital Markets CRC Ltd.

Jean-Fred Sauniere, MD, PhD – VP Business Development

Jean-Frederic Sauniere, medical oncologist, obtained his MD and PhD from the University of Medicine, Marseille, France. Dr. Sauniere brings 25 years of experience in translational, clinical research and drug development. He served as Director of Clinical Research, then Director of Corporate Licensing & Business development at Pfizer, New York and as Vice-President of Anaderm, a subsidiary of Pfizer.

Dr. Sauniere was an executive in several early stage pharmaceutical companies in the US and CEO of Shogoo Pharmaceuticals in Basel, Switzerland.

Nicola Tinari, MD, PhD – Senior Consultant R&D

Dr. Nicola Tinari is Associate Professor of Medical Oncology at the University “G. D’Annunzio” of Chieti-Pescara, Italy. He received his PhD in Molecular Oncology and is Specialist in Medical Oncology.

Dr. Tinari spent his post-doctoral training at the La Jolla Institute for Allergy and Immunology, San Diego, CA, and has been a visiting scientist at the Bristol-Myers Squibb in Seattle, WA. Dr. Tinari has more than 20 years experience in the field of translational and clinical cancer research.

Antonio Zangrilli, PhD – Chief Regulatory Affairs

Dr. Zangrilli received his degree in Economics at the University “La Sapienza” of Rome, Italy and post-graduate degree in Export Management at the Institute for Foreign Trade (I.C.E.) in Rome, Italy. He gained a strong expertise in the development of market analysis and exploitation strategies for innovative technologies due to his participation in several R&D projects


related pages:

Scientific Advisory Board

Lascia un Commento

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *


nove − = 6

È possibile utilizzare questi tag ed attributi XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>